精品国产AV,精品黄色,国产日韩欧美精品午夜一区二区三区 ,国产午夜免费视频,农民工妇女一级床片,成人永久免费视频在线观看网站 ,日韩性事,中文字幕乱码人妻二区三区

<button id="eiezk"><video id="eiezk"></video></button>

產(chǎn)品名稱

iLite? ADCC Effector (V) Assay Ready Cells from EAGLE BIOSCIENCES INC.

產(chǎn)品貨號(hào)

BM4001

產(chǎn)品價(jià)格

現(xiàn)貨詢價(jià)，電話：010-67529703

產(chǎn)品規(guī)格

250 ul

產(chǎn)品品牌

EAGLE BIOSCIENCES INC.

產(chǎn)品概述

產(chǎn)品詳情

Edit	&nbsp
Product Name	iLite? ADCC Effector (V) Assay Ready Cells
Description	iLite? ADCC Effector (V) Assay Ready Cells are based on a human T lymphocyte cell line, Jurkat (ATCC #TIB-152), and have been genetically engineered and optimized to express high levels of the low affinity Fc receptor FcγIIIa (CD16), and the Firefly Luciferase (FL) reporter gene under the control of a proprietary chimeric promoter. The FcγIIIa receptor responds to ligation of the Fc moiety of an antibody bound to the specific antigen on target cells by activation of the FL reporter gene. Normalization of cell counts, serum matrix effects or lysis of the effector cells by the target cells is obtained by a second reporter gene, a NanoLuc Luciferase reporter gene construct, under control of a constitutive promotor. ? Antibody-dependent cell-mediated cytotoxicity (ADCC) is a mechanism whereby pathogenic cells are lysed by lymphocytes, most often Natural Killer (NK) cells. The mechanism involves binding of antibodies to surface antigens on the pathogen. Crosslinking of these antibodies to NK cells through the binding of the Fc-portion to Fc receptors on the NK cells leads to activation of the NK cell and formation of an immune synapse with the pathogenic cell. The NK cell releases cytotoxic granules containing granzymes and perforin into the synapse, leading to apoptosis of the targeted cell. The idea of employing ADCC to destroy dysfunctional cells by treating patients with antibodies which induce this mechanism has existed since the discovery of the ADCC mechanism. The first monoclonal antibody for treating cancer to be FDA approved was Rituximab which in part utilizes the ADCC mechanism to destroy cancer cells expressing CD20. Induction of ADCC through monoclonal antibodies is also utilized in treating autoimmune diseases.
Size	250 ul
Concentration	n/a
Applications	RUO
Other Names	n/a
Gene, Accession, CAS #	n/a
Catalog #	BM4001
Price
Order / More Info	iLite® ADCC Effector (V) Assay Ready Cells from EAGLE BIOSCIENCES INC.
Product Specific References	n/a
產(chǎn)品資料

<button id="eiezk"><video id="eiezk"></video></button>